DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
$9.99−0.28 (-2.73%)
Close on Nov 17, 2026Market cap $628.15MP/E –Yield –
DBV Technologies gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for DBV Technologies
DBV Technologies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?